Charles Schwab Investment Management Inc. increased its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 1.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 918,699 shares of the semiconductor company’s stock after buying an additional 13,932 shares during the period. Charles Schwab Investment Management Inc. owned about 0.60% of Synopsys worth $465,220,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. ORG Partners LLC grew its holdings in Synopsys by 600.0% in the second quarter. ORG Partners LLC now owns 42 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 36 shares during the last quarter. Pacifica Partners Inc. purchased a new position in Synopsys in the third quarter worth $25,000. Tsfg LLC grew its holdings in Synopsys by 75.0% in the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 24 shares during the last quarter. Chris Bulman Inc purchased a new position in Synopsys in the second quarter worth $30,000. Finally, Hazlett Burt & Watson Inc. grew its holdings in Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 20 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Stock Performance
Shares of Synopsys stock opened at $557.73 on Friday. The firm has a 50-day simple moving average of $519.28 and a two-hundred day simple moving average of $545.55. The company has a market cap of $85.67 billion, a P/E ratio of 57.86, a price-to-earnings-growth ratio of 3.26 and a beta of 1.08. Synopsys, Inc. has a fifty-two week low of $457.52 and a fifty-two week high of $629.38.
Wall Street Analysts Forecast Growth
SNPS has been the topic of several analyst reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $640.00 price target on shares of Synopsys in a report on Tuesday, October 22nd. JPMorgan Chase & Co. boosted their price objective on shares of Synopsys from $655.00 to $685.00 and gave the company an “overweight” rating in a report on Thursday, August 22nd. Piper Sandler dropped their price objective on shares of Synopsys from $687.00 to $670.00 and set an “overweight” rating on the stock in a report on Thursday, October 24th. Loop Capital began coverage on shares of Synopsys in a report on Monday, November 11th. They set a “buy” rating and a $675.00 price objective on the stock. Finally, Rosenblatt Securities reissued a “buy” rating and set a $635.00 price objective on shares of Synopsys in a report on Friday, August 23rd. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, Synopsys has a consensus rating of “Buy” and an average price target of $649.82.
Get Our Latest Analysis on SNPS
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- Top Stocks Investing in 5G Technology
- Top 3 Financial Stocks Set to Gain From Looser Regulations
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Can BioMarin Stock Live Up to Wall Street’s High Expectations?
- How to Find Undervalued Stocks
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.